Cardio Vascular Disease
27
10
14
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
3.7%
1 terminated out of 27 trials
50.0%
-36.6% vs benchmark
4%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (27)
Support Your Heart, Phase 1
COMPARE-VENT Feasibility Pilot Study
Lifestyle Advice in CVD
An Study Looking at Percutaneous Coronary Intervention Outcomes for Octogenarians
Improving Lifestyle Habits and Metabolic Health in Forensic Psychiatric Patients
Algal Lutein Against Decline of Intellectual Nimbleness
Perioperative Vericiguat in Patients Undergoing Cardiovascular Surgery
FES Cycling With BFR in the Spinal Cord Injury Population
Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes
Qatar Cardiometabolic Retrospective Cohort-Analysis Using Artificial Intelligence
PMPR and Chlorhexidine on Periodontal Disease and Vascular Function
Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis
Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)
throMboembolic Risk Associated To High atrIal Fibrillation riSk
Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity
Assessment of the Association Between Sleep Disorders Detected by a Simplified Questionnaire and Cardiovascular Diseases
African Studies on Aging and Noncommunicable Diseases Epidemiology
Effects of Wearable Device Functions and Health Coaching on Device-measured Movement Behaviours and Cardiometabolic Risk Factors in Adults With Central Obesity
The Best Workflow for Paroxysmal Supraventricular Tachycardia Ablation With Zero-fluoroscopy
Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event